Autologous mononuclear cellular formulations for medical purposes

Pharmaceutical preparation containing mononuclear cell formulations for the treatment of heart disease, myocardial infarction, congestive heart failure, neurological disorders and ischemic injury for medical and veterinary use

Structural parts for motor vehicles; vehicle chassis; monocoque structures for vehicles

cellulose-based chromatography media

snow skis